SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001558370-21-010400
Filing Date
2021-08-05
Accepted
2021-08-05 07:51:04
Documents
3

Document Format Files

Seq Description Document Type Size
1 425 sbbp-20210805x425.htm 425 41141
2 EX-99.1 sbbp-20210805xex99d1.htm EX-99.1 441084
3 GRAPHIC sbbp-20210805xex99d1001.jpg GRAPHIC 3351
  Complete submission text file 0001558370-21-010400.txt   488669
Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053
Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200
Strongbridge Biopharma plc (Filed by) CIK: 0001634432 (see all company filings)

IRS No.: 981130690 | State of Incorp.: L2
Type: 425
SIC: 2834 Pharmaceutical Preparations

Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053
Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200
Strongbridge Biopharma plc (Subject) CIK: 0001634432 (see all company filings)

IRS No.: 981130690 | State of Incorp.: L2
Type: 425 | Act: 34 | File No.: 001-37569 | Film No.: 211146379
SIC: 2834 Pharmaceutical Preparations